UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.529

Sortiert nach

Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)

British journal of dermatology (1951), 2021-03, Vol.184 (3), p.437-449

2021

Volltextzugriff (PDF)

Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double‐blind, vehicle‐controlled trial

British journal of dermatology (1951), 2022-01, Vol.186 (1), p.40-49

2022

Volltextzugriff (PDF)

Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting

British journal of dermatology (1951), 2021-07, Vol.185 (1), p.139-146

2021

Volltextzugriff (PDF)

Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled, phase II study

British journal of dermatology (1951), 2017-08, Vol.177 (2), p.419-427

2017

Volltextzugriff (PDF)

Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis

Journal of the European Academy of Dermatology and Venereology, 2015-06, Vol.29 (6), p.1148-1155

2015

Volltextzugriff (PDF)

Efficacy and safety of dupilumab in Japanese adults with moderate‐to‐severe atopic dermatitis: a subanalysis of three clinical trials

British journal of dermatology (1951), 2020-07, Vol.183 (1), p.39-51

2020

Volltextzugriff (PDF)

Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8

British journal of dermatology (1951), 2015-01, Vol.172 (1), p.272-275

2015

Volltextzugriff (PDF)

Effective treatment by glycolic acid peeling for cutaneous manifestation of familial generalized acanthosis nigricans caused by FGFR3 mutation

Journal of the European Academy of Dermatology and Venereology, 2016-03, Vol.30 (3), p.442-445

2016

Volltextzugriff (PDF)

The nationwide cancer genome screening project in Japan, SCRUM-Japan GI-SCREEN: Efficient identification of cancer genome alterations in advanced esophageal cancer

Annals of oncology, 2018-10, Vol.29, p.viii211-viii211

2018

Volltextzugriff (PDF)

Long‐term efficacy and safety results from an open‐label phase III study (UNCOVER‐J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab

Journal of the European Academy of Dermatology and Venereology, 2019-03, Vol.33 (3), p.568-576

2019

Volltextzugriff (PDF)

Review of chemotherapeutic approaches for operable and inoperable esophageal squamous cell carcinoma

Diseases of the esophagus, 2017-02, Vol.30 (2), p.1-7

2017

Volltextzugriff (PDF)

An autoimmune bullous dermatosis with clinical, histopathological and immunological features of bullous pemphigoid and epidermolysis bullosa acquisita in an adult

British journal of dermatology (1951), 2016-10, Vol.175 (4), p.790-793

2016

Volltextzugriff (PDF)

Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection

Journal of the European Academy of Dermatology and Venereology, 2015-08, Vol.29 (8), p.1653-1655

2015

Volltextzugriff (PDF)

Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting

British journal of dermatology (1951), 2020-11, Article bjd.19673

2020

Volltextzugriff (PDF)

Updated analysis of a phase II study of SOX plus trastuzumab for the patients with HER2 positive advanced or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS1501B

Annals of oncology, 2018-10, Vol.29, p.viii225-viii225

2018

Volltextzugriff (PDF)

Initial report of a phase I/II study of S-1 and irinotecan (IRIS) in combination with cetuximab in patients with wild-type RAS metastatic colorectal cancer

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii166

2018

Volltextzugriff (PDF)

Phase II study of S-1 and oxaliplatin as neo-adjuvant chemotherapy for locally advanced gastric and esophago-gastric cancer (KSCC1601)

Annals of oncology, 2018-10, Vol.29, p.viii225-viii226

2018

Volltextzugriff (PDF)

Questionnaires to assess chronic itch: a consensus paper of the special interest group of the International Forum on the Study of Itch

Acta dermato-venereologica, 2012-01, Vol.92 (5), p.493-496

2012

Volltextzugriff (PDF)

Oxidative DNA damage in human esophageal cancer: clinicopathological analysis of 8-hydroxydeoxyguanosine and its repair enzyme

Diseases of the esophagus, 2014-04, Vol.27 (3), p.285-293

2014

Volltextzugriff (PDF)

Adiponectin as an anti-inflammatory factor in the pathogenesis of psoriasis: induction of elevated serum adiponectin levels following therapy

British journal of dermatology (1951), 2011-03, Vol.164 (3), p.667-670

2011

Volltextzugriff (PDF)

Fabrication of the low-resistive p-type ZnO by codoping method

Physica. B, Condensed matter, 2001, Vol.302, p.140-148

2001

Volltextzugriff (PDF)

A case of blue naevus of the mucocutaneous junction of the lower eyelid margin associated with acquired bilateral naevus of Ota‐like macule

Clinical and experimental dermatology, 2017-04, Vol.42 (3), p.339-341

2017

Volltextzugriff (PDF)

Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial—EPOC 2 (JFMC49-1601-C5)

ESMO open, 2021-10, Vol.6 (5), p.100277-100277, Article 100277

2021

Volltextzugriff (PDF)

Interleukin‐4 and interleukin‐13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells

Clinical and experimental immunology, 2005-09, Vol.141 (3), p.459-466

2005

Volltextzugriff (PDF)

Melanotic Malignant Melanoma in Oculocutaneous Albinism Type 4

Acta dermato-venereologica, 2017-02, Vol.97 (2), p.287-288

2017

Volltextzugriff (PDF)

1 – 25 von 2.529

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.942)
Mit Volltextzugriff
(2.152)

Publikationsform

Artikel
(2.344)
Tagungsberichte
(125)
Buchkapitel
(40)
Berichte
(14)
Bücher
(6)

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.393)
Life Sciences & Biomedicine
(1.035)
Humans
(826)
Male
(576)
Female
(551)
Biological And Medical Sciences
(515)
Animals
(400)
Middle Aged
(381)
Medical Sciences
(373)
Adult
(305)
Physical Sciences
(289)
Aged
(270)
Technology
(217)
Fundamental And Applied Biological Sciences. Psychology
(167)
Mice
(154)
Physics
(152)
Biochemistry & Molecular Biology
(137)
Exact Sciences And Technology
(136)
Chemistry
(124)
Rats
(117)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)

Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double‐blind, vehicle‐controlled trial

Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting

Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled, phase II study

Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis

Efficacy and safety of dupilumab in Japanese adults with moderate‐to‐severe atopic dermatitis: a subanalysis of three clinical trials

Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8

Effective treatment by glycolic acid peeling for cutaneous manifestation of familial generalized acanthosis nigricans caused by FGFR3 mutation

The nationwide cancer genome screening project in Japan, SCRUM-Japan GI-SCREEN: Efficient identification of cancer genome alterations in advanced esophageal cancer

Long‐term efficacy and safety results from an open‐label phase III study (UNCOVER‐J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab

Review of chemotherapeutic approaches for operable and inoperable esophageal squamous cell carcinoma

An autoimmune bullous dermatosis with clinical, histopathological and immunological features of bullous pemphigoid and epidermolysis bullosa acquisita in an adult

Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection

Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting

Updated analysis of a phase II study of SOX plus trastuzumab for the patients with HER2 positive advanced or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS1501B

Initial report of a phase I/II study of S-1 and irinotecan (IRIS) in combination with cetuximab in patients with wild-type RAS metastatic colorectal cancer

Phase II study of S-1 and oxaliplatin as neo-adjuvant chemotherapy for locally advanced gastric and esophago-gastric cancer (KSCC1601)

Questionnaires to assess chronic itch: a consensus paper of the special interest group of the International Forum on the Study of Itch

Oxidative DNA damage in human esophageal cancer: clinicopathological analysis of 8-hydroxydeoxyguanosine and its repair enzyme

Adiponectin as an anti-inflammatory factor in the pathogenesis of psoriasis: induction of elevated serum adiponectin levels following therapy

Fabrication of the low-resistive p-type ZnO by codoping method

A case of blue naevus of the mucocutaneous junction of the lower eyelid margin associated with acquired bilateral naevus of Ota‐like macule

Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial—EPOC 2 (JFMC49-1601-C5)

Interleukin‐4 and interleukin‐13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells

Melanotic Malignant Melanoma in Oculocutaneous Albinism Type 4

Suchergebnisse filtern